Salesforce, Accenture: Elevating Personalized Medicine

Salesforce and Accenture have partnered to develop specialized artificial intelligence and data solutions addressing common healthcare challenges encountered by healthcare and biopharma organizations, notably pertaining to data silos and compliance issues, according to Accenture press release. This collaboration, part of Salesforce's Life Sciences Cloud project, holds the potential to revolutionize personalized healthcare in Mexico’s fragmented health system.

Mexico's healthcare sector is grappling with significant challenges, including data fragmentation, regulatory hurdles, and the need for personalized healthcare solutions. A 2019 study by the Commonwealth Fund revealed that Mexico ranks last among 11 high-income countries in terms of access to personalized healthcare. Only 28% of Mexicans have access to personalized healthcare, far lower than the 84% average observed in other studied countries. Moreover, Statista highlights that the country’s health expenditure per capita averages at about US$1,154 annually per person, leading to shortages in healthcare providers, facilities, and longer waiting times for care.

In Mexico, the widespread adoption of personalized medicine is largely limited by the high costs associated with R&D, as reported by MBN. “The top challenges facing personalized medicine are reimbursement, reimbursement, and reimbursement,” echoes Alexis Borisy, Founder and CEO, EQRx. 

To begin to overcome these issues, enterprises like Salesforce and Accenture are pioneering transformative solutions designed to pave the way for personalized medicine. By overcoming technical barriers and ensuring data security, their initiative enables seamless cloud adoption and accelerates the integration of AI tools. This innovative approach will allow healthcare providers to access comprehensive patient data in real-time, leading to more accurate diagnoses and tailored treatment plans. Additionally, the integration of these tools will facilitate predictive analytics, empowering medical professionals to anticipate patient needs and offer proactive, personalized care. 

"The swift progress [of] science and technology [are] complicating treatment choices. Hence, data and AI will play a crucial role in distinguishing how life science organizations interact with their customers," says Emma McGuigan, Senior Managing Director, Accenture.

Furthermore, the partnership between Salesforce and Accenture is not an isolated effort, representing just one facet of a broader industry movement. Other tech giants are also actively contributing to the advancement of personalized healthcare, including Microsoft and Epic, which introduced a cloud-based electronic health records solution deployed in Mount Sinai’s Health System in August. Two months later, Google Cloud launched Med-PaLM 2, an EHR-trained large language model to provide high quality answers to medical questions. These combined endeavors emphasize the healthcare sector's readiness for innovation, showcasing a future where technology bridges the gaps and fosters personalized medicine for all.

Are you ready to set yourself up for success in 2024? Join us at Mexico Business Summit 2023, the must-attend B2B conference for Mexico’s business leaders!

Taking place on Nov. 28-30, 2023, at Expo Santa Fe in Mexico City, this high-level multi-industry conference offers unmatched opportunities to get inside perspectives on key industry trends, access actionable business intelligence, generate pre-qualified leads and identify new opportunities in a unique cross-industry networking environment.

Mexico Business News offers you an exclusive MX$2,000 ticket discount by using this code: MBS2023MBN2000. 

Don't miss this opportunity and get your tickets here: https://mexicobusiness.events/MBS/2023